<tei xml:space="preserve">
    <teiHeader>
        <fileDesc xml:id="_0"/>
    </teiHeader>
    <text xml:lang="en">
        <listBibl>
        <bibl><label>1</label>. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715<lb/> carcinoid tumors. Cancer 2003; 97: 934-59.<lb/> </bibl>
        <bibl><label>2</label>. Yao JC, Hassan M, Phan A et al. One hundred years after &quot;carci-<lb/>noid&quot;: Epidemiology of and prognostic factors for neuroendocrine<lb/> tumors in 35,825 cases in the United States. J Clin Oncol 2008;<lb/> 26: 3063-72.<lb/> </bibl>
        <bibl><label>3</label>. Scher√ºbl H. Rectal carcinoids are on the rise: Early detection by<lb/> screening endoscopy. Endoscopy 2009; 41: 162-5.<lb/> </bibl>
        <bibl><label>4</label>. Ito T, Igarashi H, Nakamura K et al. Epidemiological trends<lb/> of pancreatic and gastrointestinal neuroendocrine tumors in<lb/> Japan: A nationwide survey analysis. J Gastroenterol 2015; 50:<lb/> 58-64.<lb/> </bibl>
        <bibl><label>5</label>. Dasari A, Shen C, Halperin D et al. Trends in the incidence, preva-<lb/>lence, and survival outcomes in patients with neuroendocrine<lb/> tumors in the United States. JAMA Oncol 2017; 3: 1335-42.<lb/> </bibl>
        <bibl><label>6</label>. Kasuga A, Chino A, Uragami N et al. Treatment strategy for rectal<lb/> carcinoids: A clinicopathological analysis of 229 cases at a single<lb/> cancer institution. J Gastroenterol Hepatol 2012; 27: 1801-7.<lb/> </bibl>
        <bibl><label>7</label>. Gleeson FC, Levy MJ, Dozois EJ, Larson DW, Wong Kee Song<lb/> LM, Boardman LA. Endoscopically identified well-differentiated<lb/> rectal carcinoid tumors: Impact of tumor size on the natural<lb/> history and outcomes. Gastrointest Endosc 2014; 80: 144-51.<lb/> </bibl>
        <bibl><label>8</label>. Ngamruengphong S, Kamal A, Akshintala V et al. Prevalence of<lb/> metastasis and survival of 788 patients with T1 rectal carcinoid<lb/> tumors. Gastrointest Endosc 2019; 89: 602-6.<lb/> </bibl>
        <bibl><label>9</label>. Yamaguchi T, Takahashi K, Yamada K et al. A nationwide,<lb/> multi-institutional collaborative retrospective study of colorectal<lb/> neuroendocrine tumors in Japan. Ann Gastroenterol Surg 2021;<lb/> 5: 215-20.<lb/> </bibl>
        <bibl><label>10</label>. Ramage JK, De Herder WW, Delle Fave G et al. ENETS consen-<lb/>sus guidelines update for colorectal neuroendocrine neoplasms.<lb/> Neuroendocrinology 2016; 103: 139-43.<lb/> </bibl>
        <bibl><label>11</label>. Sivandzadeh GR, Ejtehadi F, Shoaee S et al. Endoscopic<lb/> mucosal resection: Still a reliable therapeutic option for gastroin-<lb/>testinal neuroendocrine tumors. BMC Gastroenterol 2021; 21:<lb/> 238.<lb/> </bibl>
        <bibl><label>12</label>. Niimi K, Goto O, Fujishiro M et al. Endoscopic mucosal resection<lb/> with a ligation device or endoscopic submucosal dissection for<lb/> rectal carcinoid tumors: An analysis of 24 consecutive cases. Dig<lb/> Endosc 2012; 24: 443-7.<lb/> </bibl>
        <bibl><label>13</label>. Yang DH, Park Y, Park SH et al. Cap-assisted EMR for rectal neu-<lb/>roendocrine tumors: Comparisons with conventional EMR and<lb/> endoscopic submucosal dissection (with videos). Gastrointest<lb/> Endosc 2016; 83: 1015-22.<lb/> </bibl>
        <bibl><label>14</label>. Zhang J, Liu M, Li H et al. Comparison of endoscopic therapies for<lb/> rectal carcinoid tumors: Endoscopic mucosal resection with cir-<lb/>cumferential incision versus endoscopic submucosal dissection.<lb/> Clin Res Hepatol Gastroenterol 2018; 42: 24-30.<lb/> </bibl>
        <bibl><label>15</label>. Park HW, Byeon JS, Park YS et al. Endoscopic submucosal<lb/> dissection for treatment of rectal carcinoid tumors. Gastrointest<lb/> Endosc 2010; 72: 143-9.<lb/> </bibl>
        <bibl><label>16</label>. Bang BW, Park JS, Kim HK, Shin YW, Kwon KS, Kim JM.<lb/> Endoscopic resection for small rectal neuroendocrine tumors:<lb/> Comparison of endoscopic submucosal resection with band lig-<lb/>ation and endoscopic submucosal dissection. Gastroenterol Res<lb/> Pract 2016; 2016: 1.<lb/> </bibl>
        <bibl><label>17</label>. Choi CW, Park SB, Kang DH et al. The clinical outcomes and risk<lb/> factors associated with incomplete endoscopic resection of rectal<lb/> carcinoid tumor. Surg Endosc 2017; 31: 5006-11.<lb/> </bibl>
        <bibl><label>18</label>. Harada H, Suehiro S, Murakami D et al. Endoscopic submucosal<lb/> dissection for small submucosal tumors of the rectum compared<lb/> with endoscopic submucosal resection with a ligation device.<lb/> World J Gastrointest Endosc 2017; 9: 70-6.<lb/> </bibl>
        <bibl><label>19</label>. Wang XY, Chai NL, Linghu EQ et al. The outcomes of modified<lb/> endoscopic mucosal resection and endoscopic submucosal dis-<lb/>section for the treatment of rectal neuroendocrine tumors and<lb/> the value of endoscopic morphology classification in endoscopic<lb/> resection. BMC Gastroenterol 2020; 20: 200.<lb/> </bibl>
        <bibl><label>20</label>. Mashimo Y, Matsuda T, Uraoka T et al. Endoscopic submucosal<lb/> resection with a ligation device is an effective and safe treatment<lb/> for carcinoid tumors in the lower rectum. J Gastroenterol Hepatol<lb/> 2008; 23: 218-21.<lb/> </bibl>
        <bibl><label>21</label>. Choi CW, Kang DH, Kim HW et al. Comparison of endoscopic<lb/> resection therapies for rectal carcinoid tumor: Endoscopic sub-<lb/>mucosal dissection versus endoscopic mucosal resection using<lb/> band ligation. J Clin Gastroenterol 2013; 47: 432-6.<lb/> </bibl>
        <bibl><label>22</label>. Sekiguchi M, Sekine S, Sakamoto T et al. Excellent prognosis<lb/> following endoscopic resection of patients with rectal neuroen-<lb/>docrine tumors despite the frequent presence of lymphovascular<lb/> invasion. J Gastroenterol 2015; 50: 1184-9.<lb/> </bibl>
        <bibl><label>23</label>. Ebi M, Nakagawa S, Yamaguchi Y et al. Endoscopic submu-<lb/>cosal resection with an endoscopic variceal ligation device for the<lb/> treatment of rectal neuroendocrine tumors. Int J Colorectal Dis<lb/> 2018; 33: 1703-8.<lb/> </bibl>
        <bibl><label>24</label>. Park SS, Han KS, Kim B et al. Comparison of underwater endo-<lb/>scopic mucosal resection and endoscopic submucosal dissection<lb/> of rectal neuroendocrine tumors (with videos). Gastrointest<lb/> Endosc 2020; 91: 1164-71.e2.<lb/> </bibl>
        <bibl><label>25</label>. Inada Y, Yoshida N, Fukumoto K et al. Risk of lymph node metas-<lb/>tasis after endoscopic treatment for rectal NETs 10 mm or less.<lb/> Int J Colorectal Dis 2021; 36: 559-67.<lb/> </bibl>
        <bibl><label>26</label>. Zhou X, Xie H, Xie L, Li J, Cao W, Fu W. Endoscopic resection<lb/> therapies for rectal neuroendocrine tumors: A systematic review<lb/> and meta-analysis. J Gastroenterol Hepatol 2014; 29: 259-68.<lb/> </bibl>
        <bibl><label>27</label>. Pan J, Zhang X, Shi Y, Pei Q. Endoscopic mucosal resection with<lb/> suction vs. endoscopic submucosal dissection for small rectal<lb/> neuroendocrine tumors: A meta-analysis. Scand J Gastroenterol<lb/> 2018; 53: 1139-45.<lb/> </bibl>
        <bibl><label>28</label>. Japanese Neuroendocrine Tumor Society. Clinical practice<lb/> guideline for gastroenteropancreatic neuroendocrine neoplasms<lb/> (GEP-NEN). Tokyo: Kanehara-Shuppan, 2019.<lb/> </bibl>
        <bibl><label>29</label>. Rajendran A, Pannick S, Thomas-Gibson S et al. Systematic lit-<lb/>erature review of learning curves for colorectal polyp resection<lb/> techniques in lower gastrointestinal endoscopy. Colorectal Dis<lb/> 2020; 22: 1085-100.</bibl>
        </listBibl>
    </text>
</tei>

